The LPA rs3798220 T>C polymorphism may be an independent risk factor for coronary artery disease (CAD) beyond its effect on rising Lp(a) levels.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.